Boehringer Ingelheim allocates one million Euros to fight COVID-19 in India

The package to focus on medical, sustenance support

Boehringer Ingelheim informed that it is making available one million Euros for COVID relief fund to enable sustenance and livelihoods of underserved and tribal communities, and address medical needs of patients in India, through the 2021-22 financial year.

“During these trying times, all of us at Boehringer Ingelheim are part of the collective effort in fighting COVID-19. Through our Global Support Program, we want to contribute with relevant means to the current situation and support especially those who need immediate assistance,” said Médard Schoenmaeckers, Global Head Communications & Public Affairs at Boehringer Ingelheim, overseeing the Global Support Program.

In a statement, the company said, “The relief package includes support to underserved and tribal communities in Coimbatore, Tamil Nadu, under ‘Making More Health’, Boehringer Ingelheim’s long-term social initiative. This program works on holistic development of village communities, enabling people to live healthier and empowered lives. A special focus on children’s development ensures the sustained well-being and future of the communities.”

Vani Manja, MD, Boehringer Ingelheim India said, “Boehringer Ingelheim is committed to people and patients in India. It takes all of us to tide over the current healthcare situation. Our relief package has been designed to support current medical needs and ensure that livelihoods of people in migrant and tribal communities in Maharashtra are sustained, to help them manage the unprecedented times.”

Boehringer IngelheimCOVID relief fundGlobal Support Programpharma CSRsocial initiative
Comments (0)
Add Comment